Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 718 (USA) (Dr. Nolan)
· consented 2013-05-19
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-11-16 (study day 182.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate SOMNOLENCE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-03 (study day 16.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate SOMNOLENCE — outcome: RECOVERED/RESOLVED; onset 2013-06-03 (study day 16.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.